GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BetterLife Pharma Inc (STU:NPAU) » Definitions » Operating Cash Flow per Share

BetterLife Pharma (STU:NPAU) Operating Cash Flow per Share : €-0.02 (TTM As of Jan. 2024)


View and export this data going back to 2018. Start your Free Trial

What is BetterLife Pharma Operating Cash Flow per Share?

BetterLife Pharma's operating cash flow per share for the three months ended in Jan. 2024 was €-0.00. BetterLife Pharma's operating cash flow per share for the trailing twelve months (TTM) ended in Jan. 2024 was €-0.02.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 55.70% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 53.10% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was -11.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for BetterLife Pharma's Operating Cash Flow per Share or its related term are showing as below:

STU:NPAU' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -162.1   Med: -10.4   Max: 68.1
Current: 55.7

During the past 13 years, BetterLife Pharma's highest 3-Year average Operating Cash Flow per Share Growth Rate was 68.10% per year. The lowest was -162.10% per year. And the median was -10.40% per year.

STU:NPAU's 3-Year OCF Growth Rate is ranked better than
93.36% of 1235 companies
in the Biotechnology industry
Industry Median: 3.3 vs STU:NPAU: 55.70

BetterLife Pharma Operating Cash Flow per Share Historical Data

The historical data trend for BetterLife Pharma's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BetterLife Pharma Operating Cash Flow per Share Chart

BetterLife Pharma Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
Operating Cash Flow per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.36 -0.17 -0.10 -0.01 -0.02

BetterLife Pharma Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Operating Cash Flow per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -0.01 - - -

Competitive Comparison of BetterLife Pharma's Operating Cash Flow per Share

For the Biotechnology subindustry, BetterLife Pharma's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BetterLife Pharma's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BetterLife Pharma's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where BetterLife Pharma's Price-to-Operating-Cash-Flow falls into.



BetterLife Pharma Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

BetterLife Pharma's Operating Cash Flow per Share for the fiscal year that ended in Jan. 2024 is calculated as

Operating Cash Flow per Share (A: Jan. 2024 )=Cash Flow from Operations (A: Jan. 2024 )/Shares Outstanding (Diluted Average) (A: Jan. 2024 )
=-1.691/109.286
=-0.02

BetterLife Pharma's Operating Cash Flow per Share for the quarter that ended in Jan. 2024 is calculated as

Operating Cash Flow per Share (Q: Jan. 2024 )=Cash Flow from Operations (Q: Jan. 2024 )/Shares Outstanding (Diluted Average) (Q: Jan. 2024 )
=-0.174/114.910
=-0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BetterLife Pharma Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of BetterLife Pharma's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


BetterLife Pharma (STU:NPAU) Business Description

Traded in Other Exchanges
Address
1275 West 6th Avenue, Suite 300, Vancouver, BC, CAN, V6H 1A6
BetterLife Pharma Inc a biotechnology company, engages in the development and commercialization of psychedelic products for the treatment of mental disorders in Canada, the United States, Australia, and European Union. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections, such as coronavirus disease and human papillomavirus, and/or to directly inhibit tumors to treat various types of cancer.

BetterLife Pharma (STU:NPAU) Headlines

No Headlines